Expert Interview
Discussing the FDA approval of the Revi System, a tibial nerve stimulation system developed by BlueWind Medical for overactive bladder
Ticker(s): BLUEWIND MEDICAL, MDT, PFE, ALPMFInstitution: Valley Urogynecology Associates
- Urogynecologist at Valley Urogynecology Associates
- Treats 20 patients per month for a UTI or recurrent utis and 100 for overactive bladder
- Clinical interest in pelvic floor disorders, including uterine prolapse, overactive bladder, urinary incontinence, and fecal incontinence
Describe your background and patient setting
How many patients with overactive bladder do you manage?
Added By: ben_adminWhat is your opinion of the Revi System?
Added By: ben_adminAre You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
